Literature DB >> 24600026

Overexpression of an antisense RNA, ArrS, increases the acid resistance of Escherichia coli.

Toshiko Aiso1, Shigeru Kamiya2, Hideo Yonezawa2, Shinobu Gamou1.   

Abstract

The antisense RNA ArrS is complementary to a sequence in the 5' untranslated region of the gadE T3 mRNA, the largest transcript of gadE, which encodes a transcriptional activator of the glutamate-dependent acid resistance system in Escherichia coli. Expression of arrS is strongly induced during the stationary growth phase, particularly under acidic conditions, and transcription is dependent on σ(S) and GadE. The aim of the present study was to clarify the role of ArrS in controlling gadE expression by overexpressing arrS in E. coli. The results showed a marked increase in the survival of arrS-overexpressing cells at 2 h after a shift to pH 2.5. This was accompanied by increased expression of gadA, gadBC and gadE. The level of gadE T3 mRNA decreased markedly in response to arrS overexpression, and was accompanied by a marked increase in gadE mRNA T2. T2 mRNA had a monophosphorylated 5' terminus, which is usually found in cleaved mRNAs, and no T2 mRNA was observed in an RNase III-deficient cell strain. In addition, T2 mRNA was not generated by a P3-deleted gadE-luc translational fusion. These results suggest strongly that T2 mRNA is generated via the processing of T3 mRNA. Moreover, the T2 mRNA, which was abundant in arrS-overexpressing cells, was more stable than T3 mRNA in non-overexpressing cells. These results suggest that overexpression of ArrS positively regulates gadE expression in a post-transcriptional manner.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24600026     DOI: 10.1099/mic.0.075994-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  9 in total

1.  RNase III Participates in the Adaptation to Temperature Shock and Oxidative Stress in Escherichia coli.

Authors:  Maxence Lejars; Eliane Hajnsdorf
Journal:  Microorganisms       Date:  2022-03-24

2.  PhoP induces RyjB expression under acid stress in Escherichia coli.

Authors:  Namra Siddiqui; Amit Kumar Gupta; Tanmay Dutta
Journal:  J Biochem       Date:  2022-03-03       Impact factor: 3.241

Review 3.  Trans-Acting Small RNAs and Their Effects on Gene Expression in Escherichia coli and Salmonella enterica.

Authors:  Jens Hör; Gianluca Matera; Jörg Vogel; Susan Gottesman; Gisela Storz
Journal:  EcoSal Plus       Date:  2020-03

4.  In vivo cleavage rules and target repertoire of RNase III in Escherichia coli.

Authors:  Yael Altuvia; Amir Bar; Niv Reiss; Ehud Karavani; Liron Argaman; Hanah Margalit
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

5.  Engineered global regulator H-NS improves the acid tolerance of E. coli.

Authors:  Xianxing Gao; Xiaofeng Yang; Jiahui Li; Yan Zhang; Ping Chen; Zhanglin Lin
Journal:  Microb Cell Fact       Date:  2018-07-27       Impact factor: 5.328

6.  Bacterial Cyclopropane Fatty Acid Synthase mRNA Is Targeted by Activating and Repressing Small RNAs.

Authors:  Colleen M Bianco; Kathrin S Fröhlich; Carin K Vanderpool
Journal:  J Bacteriol       Date:  2019-09-06       Impact factor: 3.490

7.  The Identity of the Constriction Region of the Ribosomal Exit Tunnel Is Important to Maintain Gene Expression in Escherichia coli.

Authors:  Sarah B Worthan; Elizabeth A Franklin; Chi Pham; Mee-Ngan F Yap; Luis R Cruz-Vera
Journal:  Microbiol Spectr       Date:  2022-03-21

8.  The coordinated action of RNase III and RNase G controls enolase expression in response to oxygen availability in Escherichia coli.

Authors:  Minho Lee; Minju Joo; Minji Sim; Se-Hoon Sim; Hyun-Lee Kim; Jaejin Lee; Minkyung Ryu; Ji-Hyun Yeom; Yoonsoo Hahn; Nam-Chul Ha; Jang-Cheon Cho; Kangseok Lee
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

Review 9.  RNase III, Ribosome Biogenesis and Beyond.

Authors:  Maxence Lejars; Asaki Kobayashi; Eliane Hajnsdorf
Journal:  Microorganisms       Date:  2021-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.